目标：尽管性少数（SM）个体进食障碍（ED）的风险增加，没有专门针对该人群的ED治疗。SM压力和基于外观的压力可能会引发和/或维持SM个体的ED症状；因此，将减少SM应激源的策略纳入现有治疗可能有助于解决SM个体增加的ED风险。这项混合方法研究评估了可行性，可接受性,促进恢复力改善饮食紊乱（PRIDE）的初步疗效-一种针对SM个体的新型ED治疗方法。
方法：N=14名诊断为ED的SM个体每周接受14次会议，将增强的ED认知行为疗法（CBT-E）与SM-CBT的技术和原则结合起来，以解决SM压力源。参与者在基线（预处理）时完成了对ED症状和SM应激反应的定性访谈和评估，后处理,和1个月的随访。
结果：支持可行性，14名参与者中有12名（85.7%）完成了治疗，定性和定量数据支持PRIDE的可接受性(定量评级=3.73/4)。通过1个月的随访，75%的样本从ED诊断中完全缓解。初步疗效结果提示ED症状有显著改善，临床损害，和身体的不满，内在化污名的显著中大改善和性取向隐瞒的不显著小中效应。
结论：初步结果支持可行性，可接受性,和PRIDE的初始功效，为解决SM压力源而开发的ED治疗。未来的研究应该在更大的样本中评估PRIDE，将其与主动控制条件进行比较，并探讨SM应激反应的减少是否可以解释ED症状的减少。
■这项研究评估了对患有ED的SM个体的治疗，该治疗将经验支持的ED治疗与SM肯定治疗相结合。结果支持这种治疗被参与者广泛接受，并与ED症状和少数民族压力结果的改善有关。
OBJECTIVE: Despite the increased risk for eating disorders (EDs) among sexual minority (SM) individuals, no ED treatments exist specifically for this population. SM stress and appearance-based pressures may initiate and/or maintain ED symptoms in SM individuals; thus, incorporating strategies to reduce SM stressors into existing treatments may help address SM individuals\' increased ED risk. This mixed-methods study evaluated the feasibility, acceptability, and preliminary efficacy of Promoting Resilience to Improve Disordered Eating (PRIDE)-a novel ED treatment for SM individuals.
METHODS: N = 14 SM individuals with an ED diagnosis received 14 weekly sessions integrating Enhanced Cognitive Behavioral Therapy for EDs (CBT-E) with techniques and principles of SM-affirmative CBT developed to address SM stressors. Participants completed qualitative interviews and assessments of ED symptoms and SM stress reactions at baseline (pretreatment), posttreatment, and 1-month follow-up.
RESULTS: Supporting feasibility, 12 of the 14 (85.7%) enrolled participants completed treatment, and qualitative and quantitative data supported PRIDE\'s acceptability (quantitative rating = 3.73/4). By 1-month follow-up, 75% of the sample was fully remitted from an ED diagnosis. Preliminary efficacy results suggested large and significant improvements in ED symptoms, clinical impairment, and body dissatisfaction, significant medium-large improvements in internalized stigma and nonsignificant small-medium effects of sexual orientation concealment.
CONCLUSIONS: Initial results support the feasibility, acceptability, and initial efficacy of PRIDE, an ED treatment developed to address SM stressors. Future research should evaluate PRIDE in a larger sample, compare it to an active control condition, and explore whether reductions in SM stress reactions explain reductions in ED symptoms.
UNASSIGNED: This study evaluated a treatment for SM individuals with EDs that integrated empirically supported ED treatment with SM-affirmative treatment in a
case series. Results support that this treatment was well-accepted by participants and was associated with improvements in ED symptoms and minority stress outcomes.
